BIOMAT Database Logo BIOMAT Database Logo

Preparation and biological evaluation of 1'-cyano-2'-C-methyl pyrimidine nucleosides as HCV NS5B polymerase inhibitors. 2014

Michael R Mish, and Aesop Cho, and Thorsten Kirschberg, and Jie Xu, and C Sebastian Zonte, and Martijn Fenaux, and Yeojin Park, and Darius Babusis, and Joy Y Feng, and Adrian S Ray, and Choung U Kim
Gilead Sciences Inc., 333 Lakeside Drive, Foster City, CA 94044, USA. Electronic address: mmish@gilead.com.

The first synthesis of 1'-cyano-2'-C-methyl pyrimidine nucleosides is described. Anti-HCV activity of these nucleosides and their nucleotide phosphoramidate prodrugs was assessed and compared to the 1'-unsubstituted counterparts and to the related 1'-cyano-2'-C-methyl C-nucleoside parent of GS-6620.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D009705 Nucleosides Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleoside,Nucleoside Analog,Nucleoside Analogs,Analog, Nucleoside,Analogs, Nucleoside
D011741 Pyrimidine Nucleosides Pyrimidines with a RIBOSE attached that can be phosphorylated to PYRIMIDINE NUCLEOTIDES. Nucleosides, Pyrimidine
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D012324 RNA-Dependent RNA Polymerase An enzyme that catalyses RNA-template-directed extension of the 3'- end of an RNA strand by one nucleotide at a time, and can initiate a chain de novo. (Enzyme Nomenclature, 1992, p293) Nucleoside-Triphosphate:RNA Nucleotidyltransferase (RNA-directed),RNA Replicase,RNA-Dependent RNA Replicase,RNA-Directed RNA Polymerase,RNA Dependent RNA Polymerase,RNA Dependent RNA Replicase,RNA Directed RNA Polymerase,RNA Polymerase, RNA-Dependent,RNA Polymerase, RNA-Directed,RNA Replicase, RNA-Dependent,Replicase, RNA,Replicase, RNA-Dependent RNA
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D016174 Hepacivirus A genus of FLAVIVIRIDAE causing parenterally-transmitted HEPATITIS C which is associated with transfusions and drug abuse. Hepatitis C virus is the type species. Hepatitis C virus,Hepatitis C-Like Viruses,Hepaciviruses,Hepatitis C Like Viruses,Hepatitis C viruses,Hepatitis C-Like Virus

Related Publications

Michael R Mish, and Aesop Cho, and Thorsten Kirschberg, and Jie Xu, and C Sebastian Zonte, and Martijn Fenaux, and Yeojin Park, and Darius Babusis, and Joy Y Feng, and Adrian S Ray, and Choung U Kim
Synthesis and evaluation of Janus type nucleosides as potential HCV NS5B polymerase inhibitors.
June 2013, Bioorganic & medicinal chemistry letters,
Michael R Mish, and Aesop Cho, and Thorsten Kirschberg, and Jie Xu, and C Sebastian Zonte, and Martijn Fenaux, and Yeojin Park, and Darius Babusis, and Joy Y Feng, and Adrian S Ray, and Choung U Kim
Quinolones as HCV NS5B polymerase inhibitors.
January 2011, Bioorganic & medicinal chemistry letters,
Michael R Mish, and Aesop Cho, and Thorsten Kirschberg, and Jie Xu, and C Sebastian Zonte, and Martijn Fenaux, and Yeojin Park, and Darius Babusis, and Joy Y Feng, and Adrian S Ray, and Choung U Kim
HCV NS5B polymerase inhibitors.
August 2009, Clinics in liver disease,
Michael R Mish, and Aesop Cho, and Thorsten Kirschberg, and Jie Xu, and C Sebastian Zonte, and Martijn Fenaux, and Yeojin Park, and Darius Babusis, and Joy Y Feng, and Adrian S Ray, and Choung U Kim
HCV NS5B polymerase inhibitors.
July 2010, Current opinion in drug discovery & development,
Michael R Mish, and Aesop Cho, and Thorsten Kirschberg, and Jie Xu, and C Sebastian Zonte, and Martijn Fenaux, and Yeojin Park, and Darius Babusis, and Joy Y Feng, and Adrian S Ray, and Choung U Kim
Synthesis and characterization of 2'-C-Me branched C-nucleosides as HCV polymerase inhibitors.
June 2012, Bioorganic & medicinal chemistry letters,
Michael R Mish, and Aesop Cho, and Thorsten Kirschberg, and Jie Xu, and C Sebastian Zonte, and Martijn Fenaux, and Yeojin Park, and Darius Babusis, and Joy Y Feng, and Adrian S Ray, and Choung U Kim
Evaluation of coumarin and neoflavone derivatives as HCV NS5B polymerase inhibitors.
May 2013, Chemical biology & drug design,
Michael R Mish, and Aesop Cho, and Thorsten Kirschberg, and Jie Xu, and C Sebastian Zonte, and Martijn Fenaux, and Yeojin Park, and Darius Babusis, and Joy Y Feng, and Adrian S Ray, and Choung U Kim
Synthesis of 2'-deoxy-2'-fluoro-2'-C-methyl spiro cyclopentyl carbocyclic uridine analog as potential inhibitors of HCV NS5B polymerase.
January 2020, Nucleosides, nucleotides & nucleic acids,
Michael R Mish, and Aesop Cho, and Thorsten Kirschberg, and Jie Xu, and C Sebastian Zonte, and Martijn Fenaux, and Yeojin Park, and Darius Babusis, and Joy Y Feng, and Adrian S Ray, and Choung U Kim
Hepatitis C therapy with HCV NS5B polymerase inhibitors.
June 2013, Expert opinion on pharmacotherapy,
Michael R Mish, and Aesop Cho, and Thorsten Kirschberg, and Jie Xu, and C Sebastian Zonte, and Martijn Fenaux, and Yeojin Park, and Darius Babusis, and Joy Y Feng, and Adrian S Ray, and Choung U Kim
Synthesis of 2'-O,4'-C-alkylene-bridged ribonucleosides and their evaluation as inhibitors of HCV NS5B polymerase.
June 2014, Bioorganic & medicinal chemistry letters,
Michael R Mish, and Aesop Cho, and Thorsten Kirschberg, and Jie Xu, and C Sebastian Zonte, and Martijn Fenaux, and Yeojin Park, and Darius Babusis, and Joy Y Feng, and Adrian S Ray, and Choung U Kim
A 2'-deoxy-2'-fluoro-2'-C-methyl uridine cyclopentyl carbocyclic analog and its phosphoramidate prodrug as inhibitors of HCV NS5B polymerase.
April 2012, Nucleosides, nucleotides & nucleic acids,
Copied contents to your clipboard!